Zambia Pharmaceutical Traceability Compliance

Discover OneScan

Global Regulations

Icon graphic element
Labelling

Products are required to display information in writing.

Graphic element
Unit Level Traceability

Sellable units are uniquely identified enabling a more granular traceability.

Summary

Zambia is implementing pharmaceutical traceability controls under the Zambia Medicines Regulatory Authority (ZAMRA). The framework focuses on standardized product identification, barcode based traceability, and improved monitoring of medicine distribution across the national supply chain.

The objective of the traceability program is to strengthen supply chain visibility, prevent falsified medicines, and support efficient product recalls and regulatory oversight.

Manufacturers, importers, distributors, and healthcare institutions supplying medicines to Zambia must adopt standardized product identification and maintain traceability records for pharmaceutical distribution.

Labelling Requirements 

Pharmaceutical products supplied to Zambia must carry machine readable barcode identification aligned with global standards.

Each pharmaceutical pack should support barcode identification containing the following data elements:

  • GTIN
  • Batch Number
  • Expiry Date

Barcodes are typically implemented using GS1 compliant barcode formats that support scanning during warehousing, distribution, and dispensing operations.

Human readable information printed on packaging must match the encoded barcode data.

Location identifiers such as Global Location Numbers (GLN) may be used to uniquely identify manufacturers, importers, distributors, warehouses, and healthcare facilities.

Regulatory Timeline 

2013 – Zambia Medicines Regulatory Authority established to regulate medicines and medical products.

2018 onward – Strengthening of supply chain oversight and implementation of systems supporting improved medicine traceability and distribution monitoring.

Ongoing – Regulatory initiatives continue to promote standardized identification and traceability across pharmaceutical supply chains.

Reporting Requirements 

Medicines Distribution Table
Operation
Data to Report
When to Report
Product Identification Setup
GTIN and product identification data
Before supplying medicines to the Zambian market
Import Documentation
Product identifiers, batch numbers, expiry dates, and shipment documentation
During import authorization and customs clearance
Distribution Records
Product identifiers, batch numbers, and shipment information
During supply chain transfers
Warehouse Receipt
Product identifiers and batch information
Upon receipt at distribution facilities
Supply to Healthcare Facilities
Product identifiers and batch details
When products are supplied to hospitals or pharmacies
Recall Support
Product identifiers, batch numbers, and distribution records
During recall or regulatory investigation

Operational Timelines for Industry 

  • Assign GTIN identifiers to pharmaceutical products supplied to Zambia.
  • Ensure packaging includes machine readable barcode identification.
  • Maintain accurate documentation for product importation and batch level distribution.
  • Ensure distributors and healthcare facilities maintain traceability records for medicine movement and storage.
  • Maintain recall readiness by ensuring product distribution records are accessible and complete.
  • Provide traceability information to ZAMRA during regulatory inspections or investigations.

Reporting Hub

Zambia does not currently operate a nationwide pharmaceutical serialization repository requiring serial level event reporting.

Traceability is supported through regulatory oversight, supply chain documentation, and electronic systems used by ZAMRA and public health procurement organizations.

Pharmaceutical supply chain participants must maintain accurate product and distribution records to support regulatory monitoring, inspections, and product recall investigations.

Aggregation Requirements 

The Zambian traceability framework focuses on batch level traceability and product identification.

Aggregation hierarchies linking individual packs to cases or pallets are not mandated as part of a national regulatory reporting system.

However, logistics units such as cases or pallets may use SSCC identifiers to support internal supply chain management and shipment tracking by manufacturers and distributors.

Common Errors to Avoid 

  • Using inconsistent product identifiers across regulatory filings and packaging.
  • Barcode data that does not match printed packaging information.
  • Incomplete distribution records that prevent effective product recall.
  • Failure to maintain traceability documentation for imported medicines.
  • Lack of standardized barcode identification across pharmaceutical products supplied to the market.

Trusted by Industry Leaders

Smooth and Successful

LSPedia didn’t just provide software; they ensured we were fully compliant. Anytime we had questions, the LSPedia team knew DSCSA inside and out and guided us step by step. That level of expertise made a huge difference during audits. Thanks to their expert team our audit was smooth and successful

Hussein Salman
Lead Pharmacist, Pioneer Pharmacy Services

Constant Commitment

LSPedia shows a constant commitment to improvement; whether it's their support or their product...they're always leveling up. The support team provides consistently thorough follow-up and clear, articulate communication. the support we receive represents a meaningful step up in service and is genuinely appreciated.

Zac Sweeny
EPCIS Data Encoder,Capital Wholesale Drug
Read All TestimonialsView Our Customers

Fill in the form for latest updates

Get in Touch

We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.

Contact Us